Group | Median survival (months) | 95% CI | p Value |
---|---|---|---|
CI, confidence interval. | |||
Group A (16 patients) | 53.00 | 15.58 to90.42 | |
p21+ and p16+ | |||
Group B (21 patients) | 34.00 | 22.04 to 45.96 | |
p21− and p16+ | |||
Group C (19 patients) | 11.00 | 6.73 to 15.27 | |
p21+ and p16− | |||
Group D (12 patients) | 6.00 | 1.58–12.11 | <0.0001 |
p21− and p16− |